PepGen Inc (PEPG)
13.21
-0.44
(-3.22%)
USD |
NASDAQ |
May 17, 16:00
13.21
0.00 (0.00%)
After-Hours: 20:00
PepGen Net Income (Quarterly): -18.02M for March 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -18.02M |
| December 31, 2023 | -19.50M |
| September 30, 2023 | -23.29M |
| June 30, 2023 | -19.52M |
| March 31, 2023 | -16.32M |
| December 31, 2022 | -14.94M |
| September 30, 2022 | -18.61M |
| Date | Value |
|---|---|
| June 30, 2022 | -17.32M |
| March 31, 2022 | -18.25M |
| December 31, 2021 | -7.144M |
| September 30, 2021 | -8.112M |
| June 30, 2021 | -5.389M |
| March 31, 2021 | -6.636M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-23.29M
Minimum
Sep 2023
-5.389M
Maximum
Jun 2021
-14.85M
Average
-17.32M
Median
Jun 2022
Net Income (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 23.28M |
| Vertex Pharmaceuticals Inc | 1.100B |
| Sarepta Therapeutics Inc | 36.12M |
| PTC Therapeutics Inc | -91.58M |
| Regenxbio Inc | -63.33M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 19.80M |
| EPS Diluted (Quarterly) | -0.63 |
| Enterprise Value | 251.39M |
| Earnings Yield | -24.62% |